CID 16020046
Chemical Name: 4-[4,6-Dihydro-4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxopyrrolo[3,4-c]pyrazol-5(1H)-yl]benzoic acid
Purity: ≥99%
Biological Activity
CID 16020046 is a selective GPR55 antagonist. Inhibits LPI-induced Ca2+ signaling (IC50 = 0.21 μM in HEK-GPR55 cells), ERK1/2 phosphorylation and GPR55-mediated transcription factor activation. Displays weak inhibition of acetylcholinesterase, μ-opioid receptor, KCNH2 and hERG. Decreases LPI-induced GPR55 internalization. Reduces experimental intestinal inflammation in mice.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
Kargl et al.
J.Pharmacol.Exp.Ther., 2013;346:54 -
The GPR55 antagonist CID16020046 protects against intestinal inflammation.
Stančić et al.
Neurogastroenterol.Motil, 2015;27:1432
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for CID 16020046
The citations listed below are publications that use Tocris products. Selected citations for CID 16020046 include:
6 Citations: Showing 1 - 6
-
THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner.
Authors: Ken Et al.
Cancers (Basel) 2021;13
-
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum.
Authors: Musella
Sci Rep 2017;7(1):7363
-
Lysophosphatidylcholine elicits intracellular calcium signaling in GPR55-dependent manner
Authors: Drzazga
Biochem Biophys Res Commun 2017;489(2):242
-
The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress.
Authors: Shi
Mol Brain 2017;10(1):38
-
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.
Authors: Katarzyna Et al.
Neural Plast 2015;2015:130639
-
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
Authors: Hofmann Et al.
Br J Pharmacol 2015;172:4107
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for CID 16020046
There are currently no reviews for this product. Be the first to review CID 16020046 and earn rewards!
Have you used CID 16020046?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image